Symptom Control and Impact on Daily Life in Patients With Gastroesophageal Reflux Disease
NCT01432392
·
clinicaltrials.gov ↗
COMPLETED
Status
1000
Enrollment
INDUSTRY
Sponsor class
Conditions
Gastroesophageal Reflux Disease
Sponsor
AstraZeneca